Learn about biosimilars and the promise they offer
Americans in need of access to safe, affordable medicines.

The Biosimilars Council

is a division of the Association for Accessible Medicines, formerly known as GPhA, that works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products, and is educating the public and patients about the safety and effectiveness of biosimilars.

What are biosimilars?

Put simply, biosimilars are biologic medicines that are highly similar to a corresponding brand biologic. Biosimilars offer a safe, effective, and affordable alternative for patients. They are approved by the U.S. Food and Drug Administration (FDA) and improve patient access to life-saving medicines. 

Biosimilars Council: A Leading Resource on Biosimilars - two doctors observing beakers

Reports, videos, news sources, and more. Take some time to learn all about biosimilars and the benefits they offer US consumers.

Biosimilars Council: A Leading Resource on Biosimilars - Doctor talking to patient

Take a minute and learn all about biosimilars and our industry in an easy to digest format. The best part? It’s free.

Biosimilars Council: A Leading Resource on Biosimilars - speaker at Atlantic Next Drug Event

We are always on the road advocating for biosimilars and invite you to join us. Check out the details for our next event and bring your friends.

Keep up-to-date with the latest
news and information on biosimilars
by signing up for our mailing list.


Press Releases


Join Our Mailing List

Receive breaking news, progress updates on regulations at both the state and federal level, and information on the future of biosimilars in the United States.
  • This field is for validation purposes and should be left unchanged.